 Prolonged continuous acyclovir treatment normal adults genital herpes simplex virus infection Acyclovir Study Group study suppressive acyclovir recurrent genital herpes patients recurrences year mg acyclovir times day recurrences mg acyclovir times day days second year study patients daily suppressive intermittent acute therapy third year daily acyclovir patients study years years suppressive therapy year acute therapy years suppressive therapy third year recurrence free year suppressive therapy-only group free years annual recurrence rate recurrences year baseline suppressive therapy acute suppressive therapy recurrences third year significant toxic effects Daily suppressive acyclovir therapy effective